LATENT TUBERCULOSIS INFECTION
Clinical trials for LATENT TUBERCULOSIS INFECTION explained in plain language.
Never miss a new study
Get alerted when new LATENT TUBERCULOSIS INFECTION trials appear
Sign up with your email to follow new studies for LATENT TUBERCULOSIS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New TB vaccine trial aims to shield millions
⭐️ VACCINE ⭐️ OngoingThis early-stage study tests a new vaccine called Ad5-105K to see if it is safe and triggers an immune response against tuberculosis (TB). About 36 healthy adults aged 18 to 49 who have been exposed to TB bacteria (but have no active disease) will receive either the vaccine or a …
Matched conditions: LATENT TUBERCULOSIS INFECTION
Phase: PHASE1 • Sponsor: CanSino Biologics Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:25 UTC
-
Could a weekly pill prevent TB in kids with HIV?
Disease control OngoingThis study tests whether a once-weekly combination of two drugs (rifapentine and isoniazid) can safely prevent tuberculosis in children and teens with HIV who are already taking the antiretroviral dolutegravir. About 92 participants aged 3 months to 17 years will receive the TB p…
Matched conditions: LATENT TUBERCULOSIS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: The Aurum Institute NPC • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a simple blood test revolutionize dormant TB detection?
Diagnosis ENROLLING_BY_INVITATIONThis study evaluates a new blood test that aims to directly detect the bacteria causing dormant tuberculosis (TB), rather than relying on the body's immune response. Current tests cannot tell if treatment worked or who will develop active TB, leading to unnecessary antibiotics. R…
Matched conditions: LATENT TUBERCULOSIS INFECTION
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Could a One-Month TB pill be as good as three? new trial tests shorter prevention
Prevention OngoingThis study tests whether taking two TB prevention drugs daily for one month works as well as taking them weekly for three months. It includes 1,000 people with HIV or those living with someone recently diagnosed with TB. The goal is to see which schedule more people complete and …
Matched conditions: LATENT TUBERCULOSIS INFECTION
Phase: PHASE4 • Sponsor: The Aurum Institute NPC • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC